Area of expertise: Drug discovery of antibacterials

Michael Barbachyn

Michael Barbachyn

Professor, Brummel Chair in Organic Chemistry
Calvin College
more
Christine Beemelmanns

Christine Beemelmanns

Head of the Department of Anti-infectives from Microbiota & Professor
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
more
Benjamin Blasco

Benjamin Blasco

Senior Discovery Project Manager
GARDP
more
Mark Blaskovich

Mark Blaskovich

Director of Translation
Institute for Molecular Bioscience, The University of Queensland
more
Kenneth Bradley

Kenneth Bradley

Global Head of Infectious Disease Discovery
Roche
more
Mark Brönstrup

Mark Brönstrup

Head of Chemical Biology
Merck & Co.
more
Heike Brötz-Oesterhelt

Heike Brötz-Oesterhelt

Professor of Microbiology, Chair Dept. Microbial Bioactive Compounds,
University of Tübingen
more
Pamela Brown

Pamela Brown

Consultant
Antibacterial Drug Discovery and Medicinal Chemistry
more
Mark S. Butler

Mark S. Butler

Director
MSBChem Consulting
more
Ryan Cirz

Ryan Cirz

Chief Scientific Officer
Revagenix, Inc.
more

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top